α
AlphaSMO
/
→
SR One Capital Management, LP
/
Q4 2021
SR One Capital Management, LP — Q4 2021 13F Holdings
CIK: 0001910264
Total reported value
$915.4M
← Back to latest quarter
Full holdings list this quarter
#
Ticker
Issuer
Asset Subclass
Weight
Weight Change
Shares Change
4Q Trend
1
DSGN
Design Therapeutics INC
Stock-Other
68.08%
-1.08%
—
2
✓
Effector Therapeutics INC
Stock-Other
31.92%
—
—